Clinical efficacy of intravenous administration of marbofloxacin in a Staphylococcus aureus infection in tissue cages in ponies.

This study examines the effectiveness of marbofloxacin on the Staphylococcus aureus infection in ponies. Despite consistent doses, the treatment didn’t successfully eliminate the infection, possibly due to the bacteria’s biofilm formation.

Study Methodology

The researchers implanted tissue cages (TC) under the skin on the necks of eight ponies. These cages were then infected with the Staphylococcus aureus (S. aureus) bacteria. The study’s main objective was to evaluate the clinical effectiveness of marbofloxacin against this specific type of infection.

• Marbofloxacin was administered once per day in doses of 6 mg/kg intravenously (into the vein) starting from 21 hours post-infection and lasting for seven days.
• The study gathered tissue cage fluid (TCF) samples on days 1, 3, and 7 post-inoculation to measure the concentration of marbofloxacin. The process of high-pressure liquid chromatography was used for this purpose.
• The samples were also analyzed for the number of viable bacteria (colony forming units or CFUs) on days 1, 3, 7, 14, and 21.

Results and Interpretation

• The marbofloxacin had only a slight impact on reducing the number of CFUs initially in all tissue cages. However, the treatment could not completely remove the infection in any of the ponies studied. This was confirmed by the formation of abscesses post-treatment.
• The researchers noted that the MIC (Minimum Inhibitory Concentration, the lowest concentration of an antibiotic that prevents bacterial growth) did not change during the course of treatment and the concentration of marbofloxacin measured in the TCF samples remained above the MIC. Therefore, it was reasonable to assume that the dosage was not the cause of treatment failure.
• Instead, the researchers concluded that the probable reason for the treatment’s lack of success could be the S. aureus bacteria’s ability to form a biofilm, a protective shield that can make bacteria more resistant to antibiotics.

Conclusion

The research concluded that intravenous administration of marbofloxacin by itself is not effective in eliminating a Staphylococcus aureus infection from secluded sites, such as the implanted tissue cages in this study. Future treatment approaches may need to consider additional measures to counteract bacterial defensive mechanisms like biofilm formation.